A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease
- 3 July 2007
- journal article
- Published by Elsevier in Neuroscience
- Vol. 147 (4), 1047-1058
- https://doi.org/10.1016/j.neuroscience.2007.05.027
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Identification of potential protein interactors of Lrrk2Parkinsonism & Related Disorders, 2007
- LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activityBiochemical Journal, 2007
- The structure of human collapsin response mediator protein 2, a regulator of axonal growthJournal of Neurochemistry, 2006
- Lack of evidence for Lrrk2 in α‐synuclein pathological inclusionsAnnals of Neurology, 2006
- Expression and localization of Parkinson's disease‐associated leucine‐rich repeat kinase 2 in the mouse brainJournal of Neurochemistry, 2006
- LRRK2 protein is a component of lewy bodiesAnnals of Neurology, 2006
- LRRK2 expression linked to dopamine‐innervated areasAnnals of Neurology, 2006
- LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brainEuropean Journal of Neuroscience, 2006
- Differentiation of the dopaminergic phenotype in the olfactory system of neonatal and adult miceJournal of Comparative Neurology, 2004
- Olfactory disturbances in parkinsonismClinical Neurology and Neurosurgery, 1980